UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Nature genetics, 2015-03, Vol.47 (3), p.263-266

2015

Volltextzugriff (PDF)

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study

Proteomics (Weinheim), 2011-03, Vol.11 (5), p.935-943

2011

Volltextzugriff (PDF)

Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001)

Journal of neuro-oncology, 2012-09, Vol.109 (3), p.565-571

2012

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3137-3143

2007

Volltextzugriff (PDF)

PNR-18PALB2 (PARTNER AND LOCALIZER OF BRCA2) HETEROZYGOUS GERMLINE MUTATION IN A CHILD WITH EXTRA OSSEOUS EWING'S SARCOMA (EOEWS) OF BRAIN AND RADIATION-INDUCED METASTATIC MELANOMA (MM)

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii10.2-iii10

2016

Volltextzugriff (PDF)

MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Suppl 3), p.iii401-iii402

2020

Volltextzugriff (PDF)

Molecular variants and mutations in medulloblastoma

Pharmacogenomics and personalized medicine, 2014-01, Vol.7 (default), p.43-51

2014

Volltextzugriff (PDF)

Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma

Neuro-oncology (Charlottesville, Va.), 2018-10, Vol.20 (11), p.1547-1555

2018

Volltextzugriff (PDF)

Determination of Cloretazine™ (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC–ESI-MS/MS)

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-06, Vol.853 (1-2), p.97-104

2007

Volltextzugriff (PDF)

Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)

Blood, 2007-11, Vol.110 (10), p.3526-3531

2007

Volltextzugriff (PDF)

MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii401-iii402

2020

Volltextzugriff (PDF)

LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

Neuro-oncology (Charlottesville, Va.), 2021-06, Vol.23 (Supplement_1), p.i32-i32

2021

Volltextzugriff (PDF)

ETMR-21. META-ANALYSIS OF PINEAL REGION TUMOURS DEMONSTRATES MOLECULAR SUBGROUPS WITH DISTINCT CLINICO-PATHOLOGICAL FEATURES: A CONSENSUS STUDY

Neuro-oncology (Charlottesville, Va.), 2020-12, Vol.22 (Supplement_3), p.iii327-iii327

2020

Volltextzugriff (PDF)

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

Journal of neuro-oncology, 2012-02, Vol.106 (3), p.643-649

2012

Volltextzugriff (PDF)

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

European journal of cancer (1990), 2010-12, Vol.46 (18), p.3287-3293

2010

Volltextzugriff (PDF)

A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study

Pediatric blood & cancer, 2013-04, Vol.60 (4), p.627-632

2013

Volltextzugriff (PDF)

Trilateral retinoblastoma: Potentially curable with intensive chemotherapy

Pediatric blood & cancer, 2010-03, Vol.54 (3), p.384-387

2010

Volltextzugriff (PDF)

PROGNOSTIC MARKER ANALYSIS IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii27-iii27

2014

Volltextzugriff (PDF)

Prognostic marker analysis in pediatric intracranial ependymomas

Journal of neuro-oncology, 2015-04, Vol.122 (2), p.255-261

2015

Volltextzugriff (PDF)

Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Nature genetics, 2015-04, Vol.47 (4), p.423-423

2015

Volltextzugriff (PDF)

Erratum: Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Nature genetics, 2015-03, Vol.47 (4), p.423-423

2015

Volltextzugriff (PDF)

Correction: Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Nature genetics, 2015, Vol.47 (4), p.423-423

2015

Volltextzugriff (PDF)

Carboplatin‐based primary chemotherapy for infants and young children with CNS tumors

Cancer, 2009-07, Vol.115 (14), p.3243-3253

2009

Volltextzugriff (PDF)

TRTH-23. FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS

Neuro-oncology (Charlottesville, Va.), 2017-06, Vol.19 (suppl_4), p.iv56-iv56

2017

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)
Buchkapitel
(1)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study

Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001)

Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study

PNR-18PALB2 (PARTNER AND LOCALIZER OF BRCA2) HETEROZYGOUS GERMLINE MUTATION IN A CHILD WITH EXTRA OSSEOUS EWING'S SARCOMA (EOEWS) OF BRAIN AND RADIATION-INDUCED METASTATIC MELANOMA (MM)

MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA

Molecular variants and mutations in medulloblastoma

Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma

Determination of Cloretazine™ (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC–ESI-MS/MS)

Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)

MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA

LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

ETMR-21. META-ANALYSIS OF PINEAL REGION TUMOURS DEMONSTRATES MOLECULAR SUBGROUPS WITH DISTINCT CLINICO-PATHOLOGICAL FEATURES: A CONSENSUS STUDY

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: A pediatric brain tumor consortium study

Trilateral retinoblastoma: Potentially curable with intensive chemotherapy

PROGNOSTIC MARKER ANALYSIS IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS

Prognostic marker analysis in pediatric intracranial ependymomas

Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Erratum: Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Correction: Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Carboplatin‐based primary chemotherapy for infants and young children with CNS tumors

TRTH-23. FEASIBILITY AND SAFETY OF SURGICAL BIOPSY FOR PATIENTS WITH DIPG: PRELIMINARY RESULTS FROM DIPG-BATS

Suchergebnisse filtern